Gilbert is a spin-off of Delft University of Technology (TU Delft) and a group of companies based at the High Tech Campus in Eindhoven, The Netherlands. 

It’s our mission to make medical treatment easier and more effective for millions of lung patients to extend and improve lives, while reducing the burden of care on the healthcare systems. 

We redefine treatment for lung patients. We believe in delivering a social contribution to the well-being of people in general and stimulating healthcare improvements in particular, using the ever-evolving technological application possibilities created by science. 

The company-based gathering of scientific findings, in a socially and economically responsible way, will be used for product development for further innovation and optimization of healthcare. With the revenues of this, we will facilitate new scientific research. 

Gilbert is developing the next generation of soft mist inhalers based on our proprietary electrospray technology to improve treatment for patients with difficult to treat lung conditions. 

Gilbert Innovation, Gilbert Therapeutics and Gilbert Technologies are subsidiaries of the Gilbert Group.